# Treatment targets in SLE: remission and low disease activity state

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-targets-in-sle-remission-and-low-disease-activity-state/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vera Golder,Michel Tsang-A-Sjoe |
| Citations | 69 |
| DOI | 10.1093/rheumatology/keaa420 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/rheumatology/article-pdf/59/Supplement_5/v19/34729973/keaa420.pdf |
| OpenAlex ID | https://openalex.org/W3111420086 |
| PMID | 33280016 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Vera Golder](https://scholariq.org/researchers/vera-golder/)

## Paper journal

- [Lara D. Veeken](https://scholariq.org/journals/lara-d-veeken/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.